Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ellis

Showing results (471-480 of 794) with videos related to

Pageof 80
Sort By:
Archives of Dermatology|September 1, 1995
Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creamsC E Griffiths, S Kang, C N Ellis, et al.
Archives of Dermatology|March 1, 1990
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysisA K Gupta, C N Ellis, B J Nickoloff, et al.
Journal of the American Academy of Dermatology|December 1, 1990
Effects of cyclosporine on renal function in psoriasis patientsJ M Messana, L L Rocher, C N Ellis, et al.
Cutis|November 1, 1988
Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percentR S Medansky, R Bressinck, G W Cole, et al.
Archives of Dermatology|May 1, 1996
Topical tretinoin (retinoic acid) improves early stretch marksS Kang, K J Kim, C E Griffiths, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipientsS E Prausa, T Fukuda, D Maseck, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatosesC A Guzzo, J S Weiss, H S Mogavero, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Second International Workshop on Y Chromosome Mapping 1995N Affara, C Bishop, W Brown, et al.
Pageof 80

Showing results (471-480 of 794) with videos related to

Sort By:
Pageof 80
Archives of Dermatology|September 1, 1995
Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creamsC E Griffiths, S Kang, C N Ellis, et al.
Archives of Dermatology|March 1, 1990
Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysisA K Gupta, C N Ellis, B J Nickoloff, et al.
Journal of the American Academy of Dermatology|December 1, 1990
Effects of cyclosporine on renal function in psoriasis patientsJ M Messana, L L Rocher, C N Ellis, et al.
Cutis|November 1, 1988
Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percentR S Medansky, R Bressinck, G W Cole, et al.
Archives of Dermatology|May 1, 1996
Topical tretinoin (retinoic acid) improves early stretch marksS Kang, K J Kim, C E Griffiths, et al.
Clinical Pharmacology and Therapeutics|February 20, 2009
UGT genotype may contribute to adverse events following medication with mycophenolate mofetil in pediatric kidney transplant recipientsS E Prausa, T Fukuda, D Maseck, et al.
Journal of the American Academy of Dermatology|May 19, 2016
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled studyJon M Hanifin, Charles N Ellis, Ilona J Frieden, et al.
Pharmacoeconomics|August 12, 2003
Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczemaCharles N Ellis, Lynn A Drake, Mary M Prendergast, et al.
Journal of the American Academy of Dermatology|December 1, 1991
A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatosesC A Guzzo, J S Weiss, H S Mogavero, et al.
Cytogenetics and Cell Genetics|January 1, 1996
Report of the Second International Workshop on Y Chromosome Mapping 1995N Affara, C Bishop, W Brown, et al.
Pageof 80